Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Jul;45(7):1160-4.
doi: 10.1111/j.1537-2995.2005.00179.x.

Purification of severe acute respiratory syndrome hyperimmune globulins for intravenous injection from convalescent plasma

Zhan Zhang  1 , Yi-Wu Xie, Jiling Hong, Xin Zhang, Sui Yi Kwok, Xiaowu Huang, Sai Wah Wong, Bing-Lou Wong; SARSIg Group
Affiliations

Purification of severe acute respiratory syndrome hyperimmune globulins for intravenous injection from convalescent plasma

Zhan Zhang et al. Transfusion. 2005 Jul.

Abstract

Background: Severe acute respiratory syndrome (SARS) is a new infectious disease caused by the SARS virus. Current first-line treatments are experimental, and their effectiveness remains open to question. For more effective treatment and prevention of SARS, human SARS hyperimmune globulins for intravenous (IV) injection were purified in this study.

Study design and methods: A combination of cold ethanol precipitation and ion-exchange chromatography was used to process pooled SARS convalescent plasma samples. Virus inactivation and removal approaches were taken to ensure safety.

Results: The purified hyperimmune globulins were formulated as a 5 percent solution, with an antibody titer specifically against the SARS virus of 1:83, 1:1600, and 1:200, as determined by enzyme-linked immunosorbent assay, immunofluorescence assay, and neutralizing antibody test, respectively. The purity of the SARS hyperimmune globulins was 99.0 percent, and the monomer and dimer content was 100 percent. Other variables analyzed met the Chinese Requirements of Biologics for IV immune globulin. The SARS hyperimmune globulins prepared were subsequently approved for clinical evaluation by the Chinese National Institute for the Control of Pharmaceutical & Biological Products.

Conclusion: IV-injectable, purified, and concentrated human SARS hyperimmune globulins were prepared from pooled convalescent plasma samples, which are ready to be further evaluated.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Simplified process for preparation of SARS hyperimmune globulins.
Figure 2
Figure 2
Distribution of SARS antibody titer.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Tsui PT, Kwok ML, Yuen H, Lai ST. Severe acute respiratory syndrome: clinical outcome and prognostic correlates. Emerg Infect Dis 2003;9: 1064‐9. - PMC - PubMed
    1. Avendano M, Derkach P, Swan S. Clinical course and management of SARS in health care workers in Toronto: a case series. CMAJ 2003;168: 1649‐60. - PMC - PubMed
    1. Loutfy MR, Blatt LM, Siminovitch KA, et al. Interferon alfacon‐1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study. JAMA 2003;290: 3222‐8. - PubMed
    1. Wong VW, Dai D, Wu AK, Sung JJ. Treatment of severe acute respiratory syndrome with convalescent plasma. Hong Kong Med J 2003;9: 199‐201. - PubMed
    1. Zhou XZ, Zhao M, Wang FS, et al. Epidemiologic features, clinical diagnosis and therapy of first cluster of patients with severe acute respiratory syndrome in Beijing area (in Chinese). Zhonghua Yi Xue Za Zhi 2003;83: 1018‐22. - PubMed

MeSH terms

-